160 studies found for:    Open Studies | "Lung Diseases, Interstitial"
Show Display Options
Rank Status Study
21 Unknown  Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study
Conditions: Pulmonary Hypertension;   Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis;   Nonspecific Interstitial Pneumonia
Interventions: Drug: Bosentan;   Drug: Placebo
22 Unknown  Pulmonary Hypertension in Interstitial Lung Disease
Conditions: Pulmonary Arterial Hypertension;   Diffuse Interstitial Lung Disease
Intervention:
23 Not yet recruiting Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
Conditions: Interstitial Lung Disease;   Scleroderma;   Idiopathic Inflammatory Myositis;   Mixed Connective Tissue Disease
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide
24 Recruiting Idiopathic Pulmonary Fibrosis Registry for Future Studies
Conditions: Lung Disease, Interstitial;   Idiopathic Pulmonary Fibrosis
Intervention:
25 Unknown  Evaluating N-Acetylcysteine in CTD-ILD Treatment
Conditions: Interstitial Lung Disease;   Connective Tissue Disease
Intervention: Drug: N-Acetylcysteine
26 Recruiting Evaluating the Effect of Oxygentherapy on Concentration at Chronic Lung Patients
Conditions: Lung Diseases, Interstitial;   Pulmonary Disease, Chronic Obstructive
Intervention: Other: oxygen therapy
27 Unknown  Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications
Conditions: Lung Neoplasm;   Lung Diseases, Interstitial;   Respiratory Tract Infections;   Pleural Effusions
Intervention: Procedure: Respiratory endoscopy
28 Unknown  Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant
Conditions: Respiratory Tract Infections;   Bronchiolitis Obliterans;   Cryptogenic Organizing Pneumonia;   Lung Diseases, Interstitial
Interventions: Drug: Prednisone;   Drug: Azithromycin;   Drug: Montelukast;   Drug: Symbicort
29 Unknown  Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD)
Conditions: Lung Disease, Chronic Obstructive;   Lung Disease, Interstitial;   Asthma;   Sarcoidosis;   Hypertension, Pulmonary
Intervention:
30 Recruiting Cardiorespiratory Response During Whole Body Vibration Training in Patients With Chronic Lung Disease
Conditions: Chronic Obstructive Lung Disease (n=10);   Interstitial Lung Disease (n=10)
Intervention: Other: Whole body vibration
31 Unknown  Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis;   Interstitial Lung Disease;   Pulmonary Hypertension
Intervention: Drug: sildenafil
32 Not yet recruiting Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis
Intervention:
33 Not yet recruiting Prediction of Everolimus-induced Interstitial Lung Disease
Condition: Breast Neoplasms
Intervention:
34 Recruiting Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Condition: Systemic Sclerosis
Intervention: Drug: Pirfenidone
35 Unknown  Endoplasmic Reticulum Stress in Chronic Respiratory Diseases
Conditions: ER Stress,;   Chronic Airway Disorders,;   Lung Cancer,;   Interstitial Lung Diseases
Intervention:
36 Recruiting A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy
Conditions: Lung Cancer;   Tuberculosis;   Sarcoidosis;   Interstitial Lung Disease
Interventions: Drug: 1% lignocaine;   Drug: 2% lignocaine
37 Recruiting Blood Collection From Individuals With Lung Disease for Genetic Studies
Conditions: Asthma;   COPD;   Interstitial Lung Disease;   Cystic Fibrosis;   Lung Cancer
Intervention:
38 Recruiting Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
Conditions: Asthma;   Chronic Obstructive Pulmonary Disease;   Interstitial Lung Disease;   Cystic Fibrosis;   Pulmonary Hypertension
Intervention: Drug: Xenon
39 Recruiting The Role of Gastroesophageal Reflux in Scleroderma Pulmonary Fibrosis
Conditions: Interstitial Lung Disease;   Systemic Sclerosis;   Gastroesophageal Reflux
Intervention: Other: Gastro-esophageal reflux
40 Recruiting GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases
Conditions: Lupus Erythematosus, Systemic;   Systemic Vasculitis;   Isolated Angiitis of Central Nervous System;   Lung Disease With Systemic Sclerosis;   Lung Disease Interstitial Diffuse
Interventions: Drug: depot leuprolide acetate 3.75 mg;   Drug: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years